Agilent AdvanceBio Peptide Mapping 120Å, 2.1 x 150 mm, 2.7 µm HPLC column 653750-902 (New)

The Agilent AdvanceBio Peptide Mapping 120Å column is a high-performance reversed-phase HPLC column specifically engineered for peptide mapping in biopharmaceutical research. With superficially porous particles and C18 chemistry, it provides outstanding efficiency, resolution, and reproducibility for peptides generated from enzymatic protein digestion.

Its stainless-steel hardware ensures durability under demanding LC and LC/MS conditions, while optimized surface chemistry delivers consistent performance across a wide pH range. The column’s 120Å pore size and 2.7 µm particle size are tailored for peptide characterization, supporting detailed analysis of protein modifications and structural studies.

Key Features

• Optimized for peptide mapping workflows in biopharma applications
• Superficially porous particles with C18 chemistry for enhanced efficiency
• High resolution and reproducibility for peptide separations
• Durable stainless-steel construction with pressure rating up to 600 bar
• Compatible with LC and LC/MS techniques
• Operates within pH 2–8 and up to 60 °C

Technical Specifications

• Brand: AdvanceBio Peptide Mapping
• Dimensions: 2.1 mm ID × 150 mm length
• Particle Size: 2.7 µm
• Pore Size: 120 Å
• Phase: C18
• Particle Type: Superficially porous
• Separation Mode: Reversed phase
• Pressure Rating: 600 bar
• Maximum Temperature: 60 °C
• pH Range: 2–8
• Material: Stainless steel hardware
• Technique: LC & LC/MS